)
Camlin Fine Sciences (CAMLINFINE) investor relations material
Camlin Fine Sciences Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 revenue was INR 572 crore (Rs. 4,572 mn), up 6% year-over-year, with blends segment growth aided by the Vinpai acquisition and vanillin sales managed for future tariff benefits.
Profitability was impacted by pricing pressure in the main ingredient (straights) business and tariff-related challenges in vanillin.
A fire at the Brazil blending unit caused significant inventory loss and operational suspension, with alternative arrangements in place and insurance claims pending.
Liquidation processes for Europe and China subsidiaries are underway, expected to halt ongoing cash bleed and have no further operational impact.
Board approved unaudited financial results for the quarter and nine months ended December 31, 2025, prepared per Indian Accounting Standards.
Financial highlights
Q3 consolidated revenue: INR 572 crore (Rs. 4,572 mn), up 6% year-over-year; 9M FY26: Rs. 13,406 mn (+9% YoY).
Vanillin sales were 490 tons (INR 55 crore) at $12.5/kg; blends revenue reached INR 271 crore, up 11% year-over-year.
Adjusted EBITDA margin for Q3: 6.7% (Rs. 307 mn); gross margin declined to 45% from 46% in the previous quarter.
Q3 PAT: Rs. -60 mn; consolidated net loss after tax for the quarter: Rs. 3,622.99 lakh, impacted by exceptional items and discontinued business losses.
Exceptional items included acquisition-related costs, provisions for labor code changes, and a doubtful advance.
Outlook and guidance
FY 2027 vanillin volume guidance is 4,000 metric tons, with 60% targeted for the U.S. and 40% for Europe.
Gross margin expected to improve to 46-47% and EBITDA margin to 12-14% in FY 2027, driven by higher vanillin realizations and blend growth.
Revenue guidance for FY 2027 is INR 2,200 crore, and INR 2,400 crore for FY 2028, assuming current price levels.
Blends business expected to grow 25% in FY 2027; Vitafor and Vinpai targeted for 40-50% top-line growth.
Management continues to monitor regulatory changes and operational risks, including new Labour Codes and ongoing legal and insurance proceedings.
- Q1 FY25 revenue dipped, but margin recovery and acquisitions set up future growth.CAMLINFINE
Q1 24/251 Feb 2026 - Q2 FY25 revenue rose, but major impairments drove a significant net loss amid global challenges.CAMLINFINE
Q2 24/2515 Jan 2026 - Revenue and margins rose, but net losses continued amid restructuring and a rights issue.CAMLINFINE
Q3 24/2523 Dec 2025 - Revenue and margins dipped, but blends growth, rights issue, and vanillin ramp-up remain on track.CAMLINFINE
Q1 25/2623 Nov 2025 - 15% revenue growth, margin gains, acquisitions, and restructuring amid wider net loss.CAMLINFINE
Q4 24/2520 Nov 2025 - Revenue up 8.6% YoY, margins improved, but losses persist amid high finance costs.CAMLINFINE
Q2 25/2610 Nov 2025
Next Camlin Fine Sciences earnings date
Next Camlin Fine Sciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)